U.S. markets closed

Momenta Pharmaceuticals, Inc. (MNTA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
52.26-0.07 (-0.13%)
At close: 4:00PM EDT

52.26 0.00 (0.00%)
After hours: 4:44PM EDT

Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
30,072
23,868
75,589
138,882
109,619
Cost of Revenue
157,488
144,542
124,004
149,226
119,880
Gross Profit
-127,416
-120,674
-48,415
-10,344
-10,261
Operating Expense
117,772
191,027
115,105
82,207
64,466
Operating Income
-245,188
-311,701
-163,520
-92,551
-74,727
Net Non Operating Interest Income Expense
-
7,188
6,194
4,427
2,226
Other Income Expense
10,170
14,458
-18,735
28
51,498
Pretax Income
-227,830
-290,055
-176,061
-88,096
-21,003
Net Income Common Stockholders
-227,830
-290,055
-176,061
-88,096
-21,003
Diluted NI Available to Com Stockholders
-227,830
-290,055
-176,061
-88,096
-21,003
Basic EPS
-
-0.0029
-0.0023
-0.0012
0
Diluted EPS
-
-0.0029
-0.0023
-0.0012
0
Basic Average Shares
-
99,339
77,845
73,136
68,656
Diluted Average Shares
-
99,339
77,845
73,136
68,656
Total Operating Income as Reported
-231,420
-298,091
-181,327
-92,551
-74,727
Total Expenses
275,260
335,569
239,109
231,433
184,346
Net Income from Continuing & Discontinued Operation
-227,830
-290,055
-176,061
-88,096
-21,003
Normalized Income
-227,878
-289,945
-158,254
-88,096
-21,003
Interest Income
-
9,206
6,194
4,427
2,226
Interest Expense
-
2,018
-
-
-
Net Interest Income
-
7,188
6,194
4,427
2,226
EBIT
-221,524
-288,037
-163,520
-92,551
-74,727
EBITDA
-217,248
-
-
-
-
Reconciled Cost of Revenue
157,488
144,542
124,004
149,226
119,880
Reconciled Depreciation
4,276
12,763
11,070
9,176
9,122
Net Income from Continuing Operation Net Minority Interest
-227,830
-290,055
-176,061
-88,096
-21,003
Total Unusual Items Excluding Goodwill
48
-110
-17,807
-
-
Total Unusual Items
48
-110
-17,807
-
-
Normalized EBITDA
-217,296
-275,164
-134,643
-83,375
-65,605
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0